BioWorld

April 14, 2008

Pinning High Hopes on Amyloid for Alzheimer

The limited effects of leading treatments for Alzheimer's disease has helped spur a growing field of research into new drug targets that could slow the course of the disease. (BioWorld Financial Watch) Read More

Money Raised By Month

Stock Winners and Losers For The Week

Phase I Clinical Trials Update: March 2008

Phase II Clinical Trials Update: March 2008

Pivotal/Phase III Clinical Trials Update: March 2008

Non-U.S. Clinical Trials And Regulatory Actions: March 2008

FDA Submissions, Approvals And Other Actions: March 2008

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for June 9, 2026.

New York University identifies new analogues of mannose-6-phosphate

BioWorld Science

New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...

ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins

BioWorld

If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...